References

1. Shillingford CA. Effective decision-making: progressing compounds through clinical development. Drug Discov Today 2001; 6(18):941-946.

2. Dimasi JA, Hansen RW, Grabowski HG. The price of innovation: New estimates of drug development costs. J Heal Econ 2003; 22:151-185.

3. Revah F. De 1040 a 10 molecules. Science & vie hors serie 2002; (218):19-26.

4. Drew J. Strategic trends in the drug industry. Drug Discov Today 2003; 8(9):411-420.

FURTHER READING

Bloom JC, Dean RA. Biomarkers in Clinical Drug Development. New York: Marcel Dekker, 2003.

Crommelin DJA, Sindelar RD. Pharmaceutical Biotechnology, An Introduction for Pharmacists and Pharmaceutical Scientists. 2nd ed. London: Routledge, 2002.

Hillisch A, Hilgenfeld R. Modern Methods in Drug Discovery. Boston, MA: Birkhauser Verlag, 2002.

Lee CJ. Development and Evaluation of Drugs from Laboratory Through Licensure to Market. Boca Raton: CRC Press, 1993.

Makriyannis A, Biegel D. Drug Discovery Strategies and Methods. New York: Marcel Dekker, 2004.

Mei HY, Czarnik AW. Integrated Drug Discovery Technologies. New York: Marcel Dekker, 2002.

Michal G. Biochemical Pathways an Atlas of Biochemistry and Molecular Biology. New York: Wiley, 1999.

Ng R. Drugs, From Discovery to Approval. Hoboken, NJ: Wiley-Liss, 2004.

Sneader W. Drug Development From Laboratory to Clinic. Chichester: Wiley, 1986.

Sneader W. Drug Discovery the Evolution of Modern Medicines. Chichester: Wiley, 1985.

Sneader W. Drug Prototypes and Their Exploitation. Chichester: Wiley, 1996.

Warne P. How Drugs are Developed: An Introduction to Pharmaceutical R&D. London: PJB Publications, 2003.

Was this article helpful?

0 0

Post a comment